0001225208-11-025361.txt : 20111123
0001225208-11-025361.hdr.sgml : 20111123
20111123164953
ACCESSION NUMBER: 0001225208-11-025361
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20111116
FILED AS OF DATE: 20111123
DATE AS OF CHANGE: 20111123
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Guilmette David D
CENTRAL INDEX KEY: 0001535396
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-08323
FILM NUMBER: 111225735
MAIL ADDRESS:
STREET 1: 900 COTTAGE GROVE ROAD
CITY: BLOOMFIELD
STATE: CT
ZIP: 06002
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CIGNA CORP
CENTRAL INDEX KEY: 0000701221
STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324]
IRS NUMBER: 061059331
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 900 COTTAGE GROVE ROAD
CITY: BLOOMFIELD
STATE: CT
ZIP: 06002
BUSINESS PHONE: 8602266000
MAIL ADDRESS:
STREET 1: 900 COTTAGE GROVE ROAD
CITY: BLOOMFIELD
STATE: CT
ZIP: 06002
FORMER COMPANY:
FORMER CONFORMED NAME: Cigna Corp
DATE OF NAME CHANGE: 20111019
FORMER COMPANY:
FORMER CONFORMED NAME: CIGNA CORP
DATE OF NAME CHANGE: 19920703
3
1
doc3.xml
X0204
3
2011-11-16
0
0000701221
CIGNA CORP
CI
0001535396
Guilmette David D
900 COTTAGE GROVE ROAD
BLOOMFIELD
CT
06002
1
Pres. Nat'l, Pharm. & Product
Common Stock, $.25 Par Value
17319.0000
D
Employee Stock Option (Right to Buy)
34.6450
2011-03-03
2020-03-03
Common Stock, $.25 Par Value
26282.0000
D
Employee Stock Option (Right to Buy)
42.1900
2012-03-01
2021-03-01
Common Stock, $.25 Par Value
10429.0000
D
This option vests in three equal annual installments. The first installment became exercisable on March 3, 2011, and the next two installments become exercisable on March 3, 2012 and March 3, 2013.
This option vests in three equal annual installments beginning March 1, 2012.
Exhibit 24 - Power of Attorney poaguilmette.txt
By: Lindsay K. Blackwood, attorney-in-fact
2011-11-23
EX-24
2
poaguilmette.txt
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that the undersigned, an officer of Cigna
Corporation, a Delaware corporation ("Cigna"), hereby makes, designates,
constitutes and appoints NICOLE S. JONES, LINDSAY K. BLACKWOOD, and AUDREY B.
TARANTO, each acting individually, as the undersigned's true and lawful
attorneys-in-fact and agents, with full power and authority to act in the
undersigned's capacity as an officer of Cigna for and in the name, place and
stead of the undersigned in connection with the filing with the Securities and
Exchange Commission pursuant to the Securities Act of 1933 or the Securities
Exchange Act of 1934, both as amended, of the execution and delivery of Forms 3,
4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of
1934, Forms 144 in accordance with Rule 144 promulgated under the Securities Act
of 1933 and any and all other documents related thereto (including, but not
limited to, Seller's Representation Letters) and to take further action as they,
or any of them, deem appropriate in connection with the foregoing.
Such attorneys-in-fact and agents, or any of them, are also hereby granted full
power and authority, on behalf of and in the name, place and stead of the
undersigned, to execute and deliver all such amendments, qualifications and
notifications; to execute and deliver any and all such other documents; and to
take further action as they, or any of them, deem appropriate in connection with
the foregoing. The powers and authorities granted herein to such
attorneys-in-fact and agents, and each of them, also include the full right,
power and authority to effect necessary or appropriate substitutions or
revocations.
The undersigned hereby ratifies, confirms, and adopts, as his own act and deed,
all action lawfully taken by such attorneys-in-fact and agents, or any of
them, or by their respective substitutes, pursuant to the powers and authorities
herein granted. This Power of Attorney shall remain in full force and effect
until the undersigned no longer has responsibilities relating to Section 16 of
the Securities Exchange Act of 1934 or Rule 144 promulgated under the Securities
Act of 1933 with respect to the undersigned's beneficial ownership of
securities of Cigna, unless earlier revoked by the undersigned in a signed
writing to each such attorney in fact.
IN WITNESS WHEREOF, the undersigned has executed this document as of
the 21st day of November, 2011.
/s/ David D. Guilmette
David Guilmette